BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10767546)

  • 1. p53 splice acceptor site mutation and increased HsRAD51 protein expression in Bloom's syndrome GM1492 fibroblasts.
    Magnusson KP; Sandström M; Ståhlberg M; Larsson M; Flygare J; Hellgren D; Wiman KG; Ljungquist S
    Gene; 2000 Apr; 246(1-2):247-54. PubMed ID: 10767546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The human RAD51/RecA homologue gene is not a candidate gene for Bloom's syndrome.
    Hellgren D; Sahlén S; Ljungqvist S; Kenne K
    Hum Genet; 1994 Dec; 94(6):705-7. PubMed ID: 7989048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GM1492 human diploid skin fibroblasts lack the p53-dependent G1 cell-cycle checkpoint.
    van Laar T; Steegenga WT; Jochemsen AG; Terleth C; van der Eb AJ
    Biochem Biophys Res Commun; 1995 Dec; 217(3):769-76. PubMed ID: 8554597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial hypercholesterolemia. Acceptor splice site (G-->C) mutation in intron 7 of the LDL-R gene: alternate RNA editing causes exon 8 skipping or a premature stop codon in exon 8. LDL-R(Honduras-1) [LDL-R1061(-1) G-->C].
    Yu L; Heere-Ress E; Boucher B; Defesche JC; Kastelein J; Lavoie MA; Genest J
    Atherosclerosis; 1999 Sep; 146(1):125-31. PubMed ID: 10487495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bloom's syndrome cells GM1492 lack detectable p53 protein but exhibit normal G1 cell-cycle arrest after UV irradiation.
    van Laar T; Steegenga WT; Jochemsen AG; Terleth C; van der Eb AJ
    Oncogene; 1994 Mar; 9(3):981-3. PubMed ID: 8108144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of p53, p21waf1/cip1 and hdm2 dependent on DNA damage in Bloom's syndrome fibroblasts.
    Collister M; Lane DP; Kuehl BL
    Carcinogenesis; 1998 Dec; 19(12):2115-20. PubMed ID: 9886565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative splicing of the p53 tumor suppressor gene in the Molt-4 T-lymphoblastic leukemia cell line.
    Chow VT; Quek HH; Tock EP
    Cancer Lett; 1993 Sep; 73(2-3):141-8. PubMed ID: 8221626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3-Methylcholanthrene inactivates the p53 gene in Syrian hamster embryo fibroblasts by inducing a specific intronic point mutation.
    Albor A; Flessate DM; Soussi T; Notario V
    Cancer Res; 1994 Aug; 54(16):4502-7. PubMed ID: 8044802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of a DNA-ligase-stimulatory factor in Bloom's syndrome cell line GM1492.
    Kenne K; Ljungquist S
    Eur J Biochem; 1988 Jun; 174(3):465-70. PubMed ID: 3391163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The genomic structure of the human SPEC1 gene reveals complex splicing and close promoter proximity to the AF1q translocation gene.
    Pirone DM; Oberst MD; Stylianou D; Burbelo PD
    Gene; 2001 Aug; 273(2):295-303. PubMed ID: 11595176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations of the p53 gene in human functional adrenal neoplasms.
    Lin SR; Lee YJ; Tsai JH
    J Clin Endocrinol Metab; 1994 Feb; 78(2):483-91. PubMed ID: 8106638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective RNA splicing resulting from a mutation in the cyclic guanosine monophosphate-phosphodiesterase beta-subunit gene.
    Piriev NI; Shih JM; Farber DB
    Invest Ophthalmol Vis Sci; 1998 Mar; 39(3):463-70. PubMed ID: 9501854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two previously unrecognized splicing mutations of GCH1 in Dopa-responsive dystonia: exon skipping and one base insertion.
    Weber Y; Steinberger D; Deuschl G; Benecke R; Müller U
    Neurogenetics; 1997 Sep; 1(2):125-7. PubMed ID: 10732814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A two-base deletion in exon 6 of the 3-hydroxy-3-methylglutaryl coenzyme A lyase (HL) gene producing the skipping of exons 5 and 6 determines 3-hydroxy-3-methylglutaric aciduria.
    Casals N; Pié J; Casale CH; Zapater N; Ribes A; Castro-Gago M; Rodriguez-Segade S; Wanders RJ; Hegardt FG
    J Lipid Res; 1997 Nov; 38(11):2303-13. PubMed ID: 9392428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of P53 mutations and their expression in 56 colorectal cancer cell lines.
    Liu Y; Bodmer WF
    Proc Natl Acad Sci U S A; 2006 Jan; 103(4):976-81. PubMed ID: 16418264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel splice site mutation in the androgen receptor gene results in exon skipping and a non-functional truncated protein.
    Lim J; Ghadessy FJ; Yong EL
    Mol Cell Endocrinol; 1997 Aug; 131(2):205-10. PubMed ID: 9296379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A wild-type DNA ligase I gene is expressed in Bloom's syndrome cells.
    Petrini JH; Huwiler KG; Weaver DT
    Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7615-9. PubMed ID: 1881902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation of tumor suppressor gene p53 is frequently found in vulvar carcinoma cells.
    Hietanen SH; Kurvinen K; Syrjänen K; Grénman S; Carey T; McClatchey K; Syrjänen S
    Am J Obstet Gynecol; 1995 Nov; 173(5):1477-82. PubMed ID: 7503188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3' Acceptor splice site mutation in intron 50 leads to mild Duchenne muscular dystrophy phenotype.
    Kekou K; Florentin L; Metaxotou C
    Hum Mutat; 1998; Suppl 1():S209-12. PubMed ID: 9452089
    [No Abstract]   [Full Text] [Related]  

  • 20. Adenomatous polyposis coli gene mutation and decreased wild-type p53 protein expression in oral submucous fibrosis: a preliminary investigation.
    Liao PH; Lee TL; Yang LC; Yang SH; Chen SL; Chou MY
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):202-7. PubMed ID: 11505268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.